Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis

Leilei He(Chongqing University), Yong Teng(Augusta University)
Journal of Experimental & Clinical Cancer Research
February 18, 2019
Cited by 49


Related Papers